tirzepatide clinical trials Who Is Right For? A Guide to Patient Selection endocrinology #clinicaltrials | NEJM Group

While alopecia appears in Wegovy's FDA label at low frequency, hair loss during semaglutide treatment more commonly results from rapid weight loss triggering telogen effluvium rather than direct drug effects

Mashiar, et al

Insomnia can also be tricky because it is another one of those non-specific symptoms

Sleep Apnea Theres a recent study with trezepetide (a semaglutide medication) indicating that it resolved up to 53% cases of sleep apnea, says Dr

If you are of Asian descent and your BMI falls between 23 and 30, have a detailed conversation with your provider about ethnicity-adjusted risk assessment

doi: 10.1056/NEJMoa1504720 6 WannerCInzucchiSELachinJMFitchettDvon EynattenMMattheusMet al